AbbVie Wins EU Approval for RINVOQ
AbbVie's RINVOQ approved for severe alopecia areata
Story updates
07:00:35 AM UTC
SquawkNews
ABBV - AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo - Click For Release
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.